⚠ Disclaimer: This report is generated using AI tools and is for informational purposes only. It does not constitute investment advice. Please consult a registered financial advisor before making any investment decisions.
FORTIS - Technical Analysis with Chart Patterns & Indicators
Back to ListTechnical Rating: 2.9
| Stock Code | FORTIS | Market Cap | 63,349 Cr. | Current Price | 839 ₹ | High / Low | 1,105 ₹ |
| Stock P/E | 343 | Book Value | 122 ₹ | Dividend Yield | 0.12 % | ROCE | 3.27 % |
| ROE | 1.41 % | Face Value | 10.0 ₹ | DMA 50 | 895 ₹ | DMA 200 | 859 ₹ |
| Chg in FII Hold | -0.06 % | Chg in DII Hold | 0.19 % | PAT Qtr | 105 Cr. | PAT Prev Qtr | 38.0 Cr. |
| RSI | 35.1 | MACD | -17.9 | Volume | 3,89,294 | Avg Vol 1Wk | 15,67,228 |
| Low price | 521 ₹ | High price | 1,105 ₹ | PEG Ratio | 2.18 | Debt to equity | 0.22 |
| 52w Index | 54.5 % | Qtr Profit Var | 9.77 % | EPS | 2.31 ₹ | Industry PE | 45.1 |
📈 Technical Analysis
- Chart Patterns: Stock corrected from 1,105 ₹ highs and is consolidating near 839 ₹, showing weakness with risk of further downside.
- Moving Averages: Current price (839 ₹) is below both 50 DMA (895 ₹) and 200 DMA (859 ₹), confirming short-term bearishness.
- RSI: At 35.1, the stock is oversold, suggesting potential for a technical rebound.
- MACD: Negative (-17.9), indicating bearish momentum persists.
- Bollinger Bands: Price is near the lower band, signaling oversold conditions but risk of breakdown.
- Volume Trends: Current volume (3,89,294) is significantly lower than 1-week average (15,67,228), showing weak participation.
📊 Momentum & Signals
- Short-Term Momentum: Weak, with oversold RSI offering limited rebound potential.
- Support Zones: 820 ₹ (near-term), 780 ₹ (major support).
- Resistance Zones: 895 ₹ (50 DMA), 950 ₹ (trendline resistance), 1,000 ₹ (psychological resistance).
- Entry Zone: 820–840 ₹ if RSI stabilizes.
- Exit Zone: 895–950 ₹ on rebound; strict stop-loss below 820 ₹.
- Trend Status: Stock is bearish and consolidating near support levels.
✅ Positive
- Quarterly PAT improved (105 Cr. vs 38 Cr.), showing earnings growth.
- DII holdings increased (+0.19 %), showing domestic institutional support.
- EPS at 2.31 ₹ provides earnings visibility.
- PEG ratio at 2.18 suggests moderate valuation relative to growth.
- Strong 52-week performance (+54.5 %) indicates investor interest.
⚠️ Limitation
- Stock trading below both 50 DMA and 200 DMA indicates weak technical strength.
- Extremely high P/E (343) compared to industry PE (45.1) suggests severe overvaluation.
- Low ROCE (3.27 %) and ROE (1.41 %) highlight poor capital efficiency.
- Dividend yield at 0.12 % offers negligible income support.
📉 Company Negative News
- FII holdings decreased (-0.06 %), showing reduced foreign investor confidence.
- Weak ROCE and ROE highlight limited efficiency in capital utilization.
- Volume participation has declined compared to weekly averages, signaling caution.
📈 Company Positive News
- Quarterly profit variance (+9.77 %) highlights earnings improvement.
- DII holdings increased (+0.19 %), showing domestic institutional confidence.
- Strong 52-week performance (+54.5 %) indicates investor interest despite weak fundamentals.
🏭 Industry
- Industry PE at 45.1 is far lower than company PE (343), suggesting FORTIS trades at a massive premium.
- Healthcare sector outlook remains positive with rising demand for medical services and hospital expansion.
🔎 Conclusion
- FORTIS is in a bearish consolidation phase after correction, with oversold RSI but weak MACD.
- Short-term traders may consider entry near 820–840 ₹ with exit around 895–950 ₹.
- Long-term investors should be cautious due to extreme valuations, poor ROE/ROCE, and weak technical signals, despite sector growth potential and improving quarterly profits.